128 related articles for article (PubMed ID: 21303423)
1. Management of asymptomatic hyperuricaemia in patients with chronic kidney disease by Japanese nephrologists: a questionnaire survey.
Nakaya I; Namikoshi T; Tsuruta Y; Nakata T; Shibagaki Y; Onishi Y; Fukuhara S;
Nephrology (Carlton); 2011 Jul; 16(5):518-21. PubMed ID: 21303423
[TBL] [Abstract][Full Text] [Related]
2. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
Fujimori S
Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
[TBL] [Abstract][Full Text] [Related]
3. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of benzbromarone in hyperuricemic patients associated with chronic kidney disease.
Fujimori S; Ooyama K; Ooyama H; Moromizato H
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1035-8. PubMed ID: 22132953
[TBL] [Abstract][Full Text] [Related]
5. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
[TBL] [Abstract][Full Text] [Related]
6. Physicians' perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey.
Cha RH; Kim SH; Bae EH; Yu M; Choi BS; Choi HY; Kang SW; Shin J; Han SY; Yang CW; Kang DH
Kidney Res Clin Pract; 2019 Sep; 38(3):373-381. PubMed ID: 31035311
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and treatment of CKD patients before and at their first nephrologist encounter in Canada.
Curtis BM; Barrett BJ; Djurdjev O; Singer J; Levin A
Am J Kidney Dis; 2007 Nov; 50(5):733-42. PubMed ID: 17954286
[TBL] [Abstract][Full Text] [Related]
8. Urate-lowering agents for asymptomatic hyperuricemia in stage 3 - 4 chronic kidney disease: Controversial role of kidney function.
Jeon HJ; Oh J; Shin DH
PLoS One; 2019; 14(6):e0218510. PubMed ID: 31206563
[TBL] [Abstract][Full Text] [Related]
9. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
10. Reported cancer screening practices of nephrologists: results from a national survey.
Wong G; Webster AC; Chapman JR; Craig JC
Nephrol Dial Transplant; 2009 Jul; 24(7):2136-43. PubMed ID: 19188339
[TBL] [Abstract][Full Text] [Related]
11. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
[TBL] [Abstract][Full Text] [Related]
12. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol].
Ohno I; Okabe H; Yamaguchi Y; Saikawa H; Uetake D; Hikita M; Gomi H; Ichida K; Hosoya T
Nihon Jinzo Gakkai Shi; 2008; 50(4):506-12. PubMed ID: 18546882
[TBL] [Abstract][Full Text] [Related]
14. A survey of current prescribing practices of antiinflammatory and urate-lowering drugs in gouty arthritis.
Stuart RA; Gow PJ; Bellamy N; Campbell J; Grigor R
N Z Med J; 1991 Mar; 104(908):115-7. PubMed ID: 2011292
[TBL] [Abstract][Full Text] [Related]
15. Assessment of nutritional practice in Italian chronic kidney disease clinics: a questionnaire-based survey.
Bellizzi V; Di Iorio BR; Brunori G; De Nicola L; Minutolo R; Conte G; Cianciaruso B; Scalfi L
J Ren Nutr; 2010 Mar; 20(2):82-90. PubMed ID: 19616451
[TBL] [Abstract][Full Text] [Related]
16. [Background of measures against chronic kidney disease].
Hishida A
Nihon Rinsho; 2008 Sep; 66(9):1639-44. PubMed ID: 18788388
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
[TBL] [Abstract][Full Text] [Related]
18. Referral to nephrologists for chronic kidney disease care: is non-diabetic kidney disease ignored?
Navaneethan SD; Nigwekar S; Sengodan M; Anand E; Kadam S; Jeevanantham V; Grieff M; Choudhry W
Nephron Clin Pract; 2007; 106(3):c113-8. PubMed ID: 17522473
[TBL] [Abstract][Full Text] [Related]
19. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
[TBL] [Abstract][Full Text] [Related]
20. Attitudes of Canadian nephrologists toward multidisciplinary team-based CKD clinic care.
Mendelssohn DC; Toffelmire EB; Levin A
Am J Kidney Dis; 2006 Feb; 47(2):277-84. PubMed ID: 16431256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
